Listen to this story

Subscriber Benefit

As a subscriber you can listen to articles at work, in the car, or while you work out. Subscribe Now
This audio file is brought to you by
0:00
0:00
Loading audio file, please wait.
  • 0.25
  • 0.50
  • 0.75
  • 1.00
  • 1.25
  • 1.50
  • 1.75
  • 2.00

Carmel-based MBX Biosciences Inc. has named James Cornelius to its board of directors. He previously served as chief executive officer and chairman of the board of Bristol Myers Squibb. 

Cornelius also served as chief financial officer at Eli Lilly and Co. from 1983 until 1995. From 2009 until 2017, he served as chairman of the board of Mead Johnson Nutrition when it was acquired by Reckitt Benckiser for $16 billion. He also served as board chairman and chief executive officer of Guidant from November 2005 to April 2006.

Cornelius earned a bachelor’s degree magna cum laude and an MBA from Michigan State University.

 

 

Story Continues Below

Big business news. Teeny tiny price. $1/week Subscribe Now

Big business news. Teeny tiny price. $1/week Subscribe Now

Big business news. Teeny tiny price. $1/week Upgrade Now

Big business news. Teeny tiny price. $1/week Upgrade Now

Your go-to for Indiana business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In

Your go-to for Indiana business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In

Your go-to for Indiana business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In

Your go-to for Indiana business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In